Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed... see more

NDAQ:LMNL - Post Discussion

View:
Post by sollmg on Jan 16, 2023 6:35pm

Ryplazim

Nice to see it made the market

May be an image of cosmetics and text that says 'NuFACTOR SHA7 aore mg/vial dnlan 6RRma/vial B plasmino 8263319111 68.8 mg/vial MA 68.8 mg/vial plasminogen, human-tvmh Ryplazim plasminogen, human-tvmh Ryplazim For Intravenous Use Only Sterile, Preservative-Free For Intravenous Use Only Sterile, Preservative-Free Single-Dose Vial Discard Unused Portion Single-Dose Vial Discard Unused Portion 2065 Rx Only'

https://www.ryplazim.com/
Comment by sollmg on Jan 16, 2023 6:38pm
And you can by it anywhere  https://insiderx.com/drugs/ryplazim/prices
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities